Terahertz radiation can disrupt proteins in living cells

Researchers from the RIKEN Center for Advanced Photonics and collaborators have discovered that terahertz radiation, contradicting conventional belief, can disrupt proteins in living cells without killing the cells. This finding implies that terahertz radiation, which was long considered impractical to use, may have applications in manipulating cell functions for the treatment of cancer, for example,…

Details

An optimal decision-making strategy emerges from non-stop learning

Unlike machines, the behaviour of animals and humans almost always has an element of unpredictability. Countless experiments have shown that our responses to the exact same challenge are sometimes faster, sometimes slower, sometimes correct and sometimes wrong. In the field of neuroscience, this variability is often attributed to what is called “noise”. An ever-present “neural…

Details

UM School of Medicine’s Institute of Human Virology awarded grants for COVID-19

The Center for International Health, Education and Biosecurity (Ciheb) at the University of Maryland School of Medicine’s Institute of Human Virology was awarded $4 million from the U.S. Centers for Disease Control and Prevention (CDC) to support coronavirus disease 2019 (COVID-19) response activities in Botswana, Nigeria, Malawi, and Mozambique. “Low-resource regions in Africa are vulnerable…

Details

Fujita Health University releases a preliminary report of Favipiravir Observational Study

Favipiravir Observational Study Group (principal investigator: Dr. Yohei Doi, Fujita Health University) released a preliminary report of the Favipiravir Observational Study in Japan on the Japanese Association for Infectious Diseases website. URL: //www.kansensho.or.jp/uploads/files/topics/2019ncov/covid19_casereport_en_200529.pdf Favipiraivr (brand name Avigan) is an anti-influenza drug which was developed by FUJIFILM Toyama Chemical Co., Ltd. Favipiravir can be administered to…

Details